
FDA classifies 750,000-unit eye drop recall as Class II over sterility concerns
The U.S. Food and Drug Administration has classified a voluntary recall of nearly 750,000 units of eye drops and ointments as Class II, citing a lack of assurance of sterility. Initiated by Sterling Pharmaceutical Services LLC in August 2026, the recall affects nine products sold under brands including Walgreens, AvKare, and Reliable-1. Consumers are advised to check lot numbers and expiration dates against FDA records and discontinue use if their products are affected.




